Medicine and Dentistry
Infliximab
100%
Adalimumab
87%
Uveitis
75%
Steroid
62%
Spontaneous Remission
50%
Therapeutic Procedure
50%
Patient
37%
Pediatrics
37%
Combination Therapy
25%
Diseases
12%
Follow up
12%
Disease Activity
12%
Adverse Event
12%
Cohort Analysis
12%
Pediatrics Patient
12%
Dependent Personality Disorder
12%
Iridocyclitis
12%
Retina Macula Cystoid Edema
12%
Intermediate Uveitis
12%
Retinal Vasculitis
12%
Analysis
12%
Child
12%
Incidence
12%
Medical Record
12%
Pharmacology, Toxicology and Pharmaceutical Science
Infliximab
100%
Adalimumab
87%
Uveitis
75%
Steroids
62%
Remission
50%
Diseases
12%
Adverse Event
12%
Comorbidity
12%
Disease Activity
12%
Iridocyclitis
12%
Incidence
12%
Dependent Personality Disorder
12%
Retina Macula Cystoid Edema
12%
Intermediate Uveitis
12%
Retina Vasculitis
12%
Neuroscience
Infliximab
100%
Adalimumab
87%
Steroids
62%
Uveitis
62%
Pediatrics
50%
Anterior Uveitis
12%
Panuveitis
12%
Cystoid Macular Edema
12%
Dependent Personality Disorder
12%
Comorbidity
12%